Stock listing

gettex:EN9 Enzymatica AB Aktie

German listing (gettex) of Enzymatica AB · home listing Stockholm:ENZY

Follow Enzymatica AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:ENZY

2.32 SEK -0.08 (-3.3%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:ENZY

Past year +18.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
2.20 – 2.49 SEKNov 20, 2026
Volume
50,892 sharesNov 20, 2026
Market cap
563.1M SEKAt the close on Nov 20, 2026 · price × 242.7M shares outstanding
52-week range
1.55 – 3.40 SEKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
219,881 SEKMedian day 73,156 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Enzymatica AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:ENZY · Home2.32 SEK-0.08 (-3.3%)50,8922.292.492.202.40Close on Nov 20, 2026
Frankfurt:EN9€0.177 EUR-0.009 (-4.6%)—€0.173€0.177€0.173€0.185Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXSTO:ENZY · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
2.32-0.08-3.3%2.292.492.2050,892
2.40+0.03+1.3%2.372.402.3228,706
2.37-0.08-3.3%2.452.452.3334,088
2.45-0.06-2.4%2.442.542.4032,170
2.51+0.05+2.0%2.412.602.4156,249
2.46-0.03-1.2%2.492.542.38181,650
2.49+0.04+1.6%2.432.552.39113,960
2.45+0.20+8.9%2.272.452.2779,009
2.25-0.34-13.1%2.592.642.25296,804
2.59+0.39+17.7%2.202.592.19546,727
2.20-0.10-4.3%2.302.302.2049,613
2.30+0.03+1.3%2.292.452.20175,379
2.27+0.14+6.6%2.192.272.1987,812
2.13-0.02-0.9%2.162.251.985396,649
2.15+0.11+5.4%2.002.151.95359,887
2.04+0.11+5.7%1.9752.081.8999,958
1.93-0.05-2.5%1.9751.9751.855128,392
1.98+0.035+1.8%1.9451.981.90542,693
1.945-0.005-0.3%1.951.951.82548,364
1.95+0.005+0.3%1.952.101.885124,325
1.945+0.035+1.8%1.901.9451.9047,296
1.91+0.01+0.5%1.901.9851.85557,063
1.90+0.20+11.8%1.702.001.70191,284
1.70-0.06-3.4%1.751.771.69546,271
1.76+0.06+3.5%1.6951.761.6799,076
1.70-0.07-4.0%1.761.771.70440,245
1.77+0.065+3.8%1.7751.7751.695246,346
1.705-0.04-2.3%1.751.751.66552,598
1.745+0.045+2.6%1.7051.7451.7013,368
1.70-0.03-1.7%1.7351.7451.7020,989
1.73-0.05-2.8%1.781.791.69575,633
1.78-0.01-0.6%1.7851.7851.7131,245
1.79+0.055+3.2%1.6751.791.67524,436
1.735+0.025+1.5%1.651.761.64598,369
1.71-0.015-0.9%1.6351.7151.63532,140
1.725-0.005-0.3%1.681.7251.60583,464
1.73+0.065+3.9%1.6351.731.6349,134
1.665-0.025-1.5%1.6851.721.62515,513
1.69-0.01-0.6%1.5651.7251.565113,911
1.700.000.0%1.671.871.55139,694
1.70+0.005+0.3%1.701.7351.67597,685
1.695-0.10-5.6%1.7751.781.67241,202
1.795-0.065-3.5%1.861.861.77144,266
1.86+0.01+0.5%1.8451.971.8236,815
1.85-0.05-2.6%1.911.911.8570,678
1.90-0.07-3.6%1.911.971.9040,574
1.97-0.07-3.4%1.9351.9951.92536,648
2.04-0.03-1.4%2.022.091.9547,335
2.07-0.08-3.7%2.142.142.0612,714
2.150.000.0%2.162.192.0847,561
2.15+0.05+2.4%2.092.152.01157,192
2.10+0.08+4.0%2.012.161.955149,511
2.020.000.0%2.132.161.92118,324
2.02+0.17+9.2%1.8552.221.855237,957
1.85+0.015+0.8%1.851.851.80116,529
1.835-0.01-0.5%1.8151.8551.80543,567
1.845+0.035+1.9%1.791.8651.78569,470
1.81+0.01+0.6%1.801.821.765102,699
1.80+0.04+2.3%1.751.801.74552,304
1.76-0.14-7.4%1.891.891.65177,342
1.90+0.05+2.7%1.9251.9251.901,530
1.85-0.01-0.5%1.8551.9051.8561,865
1.86-0.065-3.4%1.901.941.8579,098
1.925-0.02-1.0%1.8951.9451.8911,807

Splits

1 split · OMXSTO:ENZY · every price before a split is adjusted for it

DayRatioWhat
75-for-73Split
Ticker
gettex:EN9
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
gettex
Currency
EUR

What changed lately

Latest news

All Enzymatica AB news

Enzymatica AB on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
7 in the last 12 months · 13 in all · newest Jun 9, 2026 · oldest 2025
Decks
1 deck · latest 2021

Where Enzymatica AB is listed

ListingExchangeCountryCurrency
Stockholm:ENZY · Home listingStockholmSwedenSEK
LS Exchange:A1WZEVLS ExchangeGermanyEUR
Lang & Schwarz:A1WZEVLang & SchwarzGermanyEUR
gettex:EN9 · This pagegettexGermanyEUR
Munich:EN9MunichGermanyEUR
Frankfurt:EN9FrankfurtGermanyEUR
Stuttgart:EN9StuttgartGermanyEUR

Valuation

EV/sales 11.1× against a median of 2.2×: the highest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
570.3M SEK
P/E
Loss
EV/sales
11.1×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
6.0×
Gross margin
58.8%
Operating margin
−79.4%
Net margin
−80.5%
Debt to equity
0.1×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Enzymatica AB · OMXSTO:ENZYUS$55.08MUS$55.77Mn/a11.1×n/a6.0×−80.5%0.1×n/a
REMED Co., Ltd. · KRX:302550US$57.50MUS$51.61M37.5×2.5×20.4×2.0×7.6%0.1×n/a
Vincent Medical Holdings Limited · HKEX:1612US$57.26MUS$62.46M4.3×0.5×2.9×0.6×11.2%0.3×n/a
OK Biotech Co., Ltd. · TWSE:4155US$55.10MUS$75.16M7.5×1.6×7.9×0.7×15.8%0.4×n/a
LENSAR, Inc. · NASDAQ:LNSRUS$54.83MUS$44.40M1.6×0.7×18.0×5.0×56.1%0.2×0.76
P&S Robotics Co., Ltd. · KRX:460940US$54.71MUS$33.83M26.6×5.9×36.6×1.7×36.0%0.0×n/a
Creo Medical Group PLC · LSE:CREOUS$54.06MUS$49.48M7.8×6.3×n/a0.9×88.3%0.1×n/a
Crystalvue Medical Co Ltd · TPEX:6527US$53.82MUS$52.19M12.1×1.8×8.7×1.7×15.5%0.0×n/a
3D Global Biotech Inc. · TPEX:6808US$53.26MUS$38.17M26.4×6.1×17.5×2.4×32.2%0.0×n/a
Outset Medical, Inc. · NASDAQ:OMUS$53.03MUS$14.77Mn/a0.1×n/a0.6×−58.3%1.2×1.74
NeurAxis, Inc. · AMEX:NRXSUS$52.99MUS$48.80Mn/a7.5×n/a14.6×−185.2%0.1×1.77
Median of the othersUS$54.38MUS$49.14M9.9×2.2×17.5×1.7×15.6%0.1×1.74

Team and board

OfficerRole
Sana AlajmovicChief Executive Officer of Enzymatica AB
Holger LembrérCFO
Anja TrägårdhCorporate Communications
Katja MargellDirector of Investor Relations & Corporate Affairs
Joakim Tingström NordinNordic Marketing and Sales Director

Events

QuarterResultsShare move
Q3 2026Oct 30, 2026+8.0%
Q2 2026Jul 17, 2026+0.5%
Q1 2026Apr 27, 2026 · Before open−4.6%
Q4 2025Feb 16, 2026 · Before open−1.2%
Q3 2025Oct 30, 2025 · Before open+2.0%
Q2 2025Jul 27, 2025 · Before open+0.4%
Q1 2025Apr 29, 2025 · Before open−6.9%
Q4 2024Feb 18, 2025 · Before open0.0%
Q3 2024Nov 7, 2024 · Before open+0.6%
Q2 2024Jul 18, 2024 · Before open−16.9%
All 20 quarters
QuarterResultsShare move
Q1 2024Apr 25, 2024 · Before open−8.2%
Q4 2023Feb 16, 2024 · Before open−6.2%
Q3 2023Nov 7, 2023 · Before open−11.1%
Q2 2023Jul 18, 2023 · Before open+5.8%
Q1 2023Apr 27, 2023 · Before open+17.7%
Q4 2022Feb 17, 2023 · Before open−18.8%
Q3 2022Nov 2, 2022 · Before open−7.0%
Q2 2022Jul 19, 2022 · Before open−1.4%
Q1 2022Apr 28, 2022 · Before open−13.9%
Q4 2021Feb 17, 2022 · Before open0.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (2021)Investor deck32 slides2021

Open Decks

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue53.9M45.6M50.9M48.9M57.2M111.2M61.3M52.6M59.4M36.5M
Cost of revenue20.8M14.9M19.0M20.5M23.9M35.3M16.4M15.8M23.1M14.3M
Gross profit33.1M30.7M31.9M28.5M33.4M76.0M44.9M36.8M36.3M22.2M
Research and development15.7M15.5M15.2M26.5M24.2M22.5M28.5M20.8M14.4M12.3M
Selling, general and administrative42.2M41.3M39.4M38.7M32.8M40.7M29.0M28.6M27.3M26.2M
Operating income-52.2M-52.1M-48.1M-68.2M-45.2M-12.1M-41.7M-40.6M-30.2M-46.2M
Depreciation and amortization5.40M5.81M6.51M7.78M6.63M7.03M7.08M6.23M5.36M2.79M
EBITDA-46.8M-46.2M-41.6M-60.4M-38.6M-5.03M-34.6M-34.3M-24.9M-43.4M
Interest expense1.23M1.91M2.09M997.0K889.0K804.0K1.47M2.34M536.0K1.43M
Income before tax-51.8M-53.3M-49.7M-68.7M-45.7M-13.1M-41.9M-42.1M-30.9M-46.8M
Income tax-51.0K-159.0K9.00K-90.0K-307.0K159.0K-961.0K429.0K576.0K-1.83M
Net income-51.9M-53.2M-49.7M-68.7M-45.4M-13.2M-41.0M-42.6M-31.4M-45.0M
Earnings per share, basic-0.21-0.28-0.28-0.41-0.31-0.09-0.29-0.45-0.35-0.68

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents33.1M75.2M8.37M50.7M31.6M24.0M29.3M70.3M10.9M35.6M
Receivables10.6M13.6M12.5M17.7M18.8M32.8M16.0M11.0M17.8M10.3M
Inventory18.9M16.7M11.5M11.5M12.4M10.5M7.00M5.55M2.69M6.99M
Current assets65.0M112.0M38.8M84.8M64.8M71.5M54.7M90.0M32.4M56.3M
Property, plant and equipment10.4M14.4M16.5M16.4M15.2M10.3M6.78M4.54M4.87M4.38M
Goodwill63.2M63.2M63.2M63.2M63.2M63.2M63.2M63.2M63.2M63.2M
Total assets142.0M195.2M125.9M174.4M157.0M162.0M147.7M185.2M133.8M162.6M
Accounts payable8.75M9.81M7.37M6.67M7.61M13.9M10.4M10.2M6.31M4.48M
Current liabilities17.8M17.8M32.4M27.0M30.9M53.3M24.6M21.6M17.5M13.2M
Long-term debt8.00K014.9M20.9M0233.0K2.09M3.87M5.65M5.83M
Total debt1.02M2.20M18.1M22.3M2.60M14.5M5.57M4.78M8.31M8.57M
Total liabilities17.8M18.9M49.3M48.1M32.1M55.4M28.5M25.5M23.1M20.6M
Shareholders' equity124.2M176.4M76.6M126.3M125.0M106.6M119.2M159.7M110.3M141.7M
Shares outstanding242.7M192.7M177.6M166.9M146.7M142.9M142.9M95.3M90.9M66.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-41.0M-60.5M-40.3M-64.6M-35.9M-10.7M-37.6M-28.8M-22.5M-38.4M
Capital spending-231.0K-393.0K-730.0K-3.72M-6.13M-4.84M-866.0K-520.0K-1.26M-13.9M
Free cash flow-41.2M-60.9M-41.0M-68.3M-42.0M-15.5M-38.4M-29.3M-23.8M-52.3M
Cash from investing-231.0K-393.0K-730.0K-3.72M-6.13M-4.84M-866.0K-520.0K-1.26M-19.0M
Cash from financing-789.0K127.7M-1.39M87.4M49.5M10.0M-2.53M88.7M-846.0K84.6M
Share buybacks390.0K159.3M074.7M66.7M2.54M098.7M0100.2M
Change in cash-42.1M66.8M-42.3M19.1M7.60M-5.30M-41.0M59.4M-24.7M27.5M

Open Financials

Cap table

Built by 6ix from Enzymatica AB’s releases

Common shares
242,735,108
Fully diluted
242,735,108

Fully diluted

LineShares
Common shares242,735,108

Share count over time

CountShares
Nov 22, 2026242,735,108

Open Cap table

Shareholders

TradeTradeSharesPriceValueDate
Sana Alajmovic
Chief Executive Officer (CEO)/Managing Directory
Buy10,869SEK 1.84SEK 19,999Sep 1, 2026
Sana Alajmovic
Chief Executive Officer (CEO)/Managing Directory
Buy15,555SEK 1.85SEK 28,777Sep 1, 2026
Sana Alajmovic
Chief Executive Officer (CEO)/Managing Directory
Buy33,384SEK 1.81SEK 60,395Aug 28, 2026
Holger Lembrér
Chief Financial Officer (CFO)
Buy50,000SEK 2.20SEK 110KJul 17, 2026
Anna Söderlund
Other senior executive
Sale40,000SEK 3.00SEK 120KMar 31, 2026
Bengt Baron
Chairman of the Board of Directors
Buy20,000SEK 1.88SEK 37,514Dec 29, 2025
Bengt Baron
Chairman of the Board of Directors
Buy20,000SEK 1.88SEK 37,568Dec 23, 2025
Bengt Baron
Chairman of the Board of Directors
Buy5,500SEK 1.88SEK 10,340Dec 23, 2025
Bengt Baron
Chairman of the Board of Directors
Buy10,000SEK 1.85SEK 18,500Dec 22, 2025
Bengt Baron
Chairman of the Board of Directors
Buy10,000SEK 1.82SEK 18,179Dec 22, 2025
All 16 trades
TradeTradeSharesPriceValueDate
Bengt Baron
Chairman of the Board of Directors
Buy20,000SEK 1.79SEK 35,810Dec 22, 2025
Bengt Baron
Chairman of the Board of Directors
Buy30,000SEK 1.88SEK 56,400Dec 22, 2025
Bengt Baron
Chairman of the Board of Directors
Buy50,000SEK 1.87SEK 93,665Dec 22, 2025
Bengt Baron
Chairman of the Board of Directors
Buy20,000SEK 1.84SEK 36,832Dec 22, 2025
Bengt Baron
Chairman of the Board of Directors
Buy18,935SEK 1.85SEK 35,030Dec 22, 2025
Bengt Baron
Chairman of the Board of Directors
Buy10,000SEK 1.85SEK 18,499Dec 22, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Anja TrägårdhCorporate Communications · Since at least Mar 31, 2026
Holger LembrérCFO · Since at least Feb 18, 2026
Joakim Tingström NordinNordic Marketing and Sales Director · Since at least Jun 9, 2026
Sana AlajmovicChief Executive Officer of Enzymatica AB · Since at least Feb 18, 2026

Open People

Log in to ask 6ix AI your own questions about Enzymatica AB.